American Heart Journal
Volume 146, Issue 5 , Pages 787-796 , November 2003

Percutaneous coronary intervention: historical perspectives, current status, and future directions

  • Heidar Arjomand, MD

      Affiliations

    • Department of Medicine, Drexel University College of Medicine, Philadelphia, Pa, USA
    • ,
  • Zoltan G Turi, MD

      Affiliations

    • Department of Medicine, Drexel University College of Medicine, Philadelphia, Pa, USA
    • ,
  • Daniel McCormick, DO

      Affiliations

    • Department of Medicine, Drexel University College of Medicine, Philadelphia, Pa, USA
    • ,
  • Sheldon Goldberg, MD

      Affiliations

    • Department of Medicine, Drexel University College of Medicine, Philadelphia, Pa, USA
    • Corresponding Author InformationReprint requests: Sheldon Goldberg, MD, Hahnemann University Hospital, 230 North Broad Street, 7th floor, South Tower, MS-108, Philadelphia, PA 19107, USA.

Received 20 August 2002 ,Accepted 19 February 2003.

References 

  1. Favaloro RG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion (operative technique). Ann Thorac Surg. 1968;5:334–339
  2. Gruntzig AR. Transluminal dilatation of coronary-artery stenosis. Lancet. 1978;1:263
  3. Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary artery stenosis (percutaneous transluminal coronary angioplasty). N Engl J Med. 1979;301:61–68
  4. Holmes DR, Vliestra RE, Smith HC, et al.  Restenosis after percutaneous transluminal coronary angioplasty (a report from the PTCA Registry of NHLBI). Am J Cardiol. 1984;53:77–81C
  5. Baim DS, Hinohara T, Holmes D, et al.  Results of directional coronary atherectomy during multicenter preapproval testing. Am J Cardiol. 1993;72:6–11E
  6. Rihal CS, Garratt KN, Holmes DR. Rotational atherectomy for bifurcation lesions of the coronary circulation (technique and initial experience). Int J Cardiol. 1998;65:1–9
  7. Litvack F, Grundfest WS, Papaioannou T, et al.  Role of laser and thermal ablation devices in the treatment of cardiovascular diseases. Am J Cardiol. 1988;61:81–86G
  8. Sigwart U, Puel J, Mirkovitch V, et al.  Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987;316:701–706
  9. Williams DO, Holubkov R, Yeh W, et al.  Percutaneous coronary intervention in the current era compared with 1985–1986 (the NHLBI Registries). Circulation. 2000;102:2945–2951
  10. Arjomand H, Willerson JT, Holmes DR, et al.  Current status of percutaneous coronary intervention (results from a large international trial). J Am Coll Cardiol. 2003;41:23A
  11. Detre K, Holubkov R, Kelsey S, et al.  Percutaneous transluminal coronary angioplasty in 1985–1986 and 1977–1981 (the NHLBI Registry). N Engl J Med. 1988;318:265–270
  12. Ellis SG, Roubin GS, King SB, et al.  In-hospital cardiac mortality after acute closure after coronary angioplasty (analysis of risk factors from 8,207 procedures). J Am Coll Cardiol. 1988;11:211–216
  13. Bredlau CE, Roubin GS, Leimgruber PP, et al.  In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation. 1985;72:1044–1052
  14. Topol EJ, Leya F, Pinkerton CA, et al.  A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med. 1993;329:221–227
  15. Holmes DR, Topol EJ, Califf RM, et al.  A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. Circulation. 1995;91:1966–1974
  16. Simonton CA, Leon MB, Baim DS, et al.  “Optimal” directional coronary atherectomy (final results of the OARS study). Circulation. 1998;97:332–339
  17. Simonton CA. The role of coronary atherectomy. In:  Ellis SG,  Holmes DR editor. Strategic approaches in coronary intervention. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2000;p. 229–232
  18. Moussa I, Di Mario C, Moses J, et al.  Coronary stenting after rotational atherectomy in calcified complex lesions (angiographic and clinical follow-up results). Circulation. 1997;96:128–136
  19. Reifart N, Vandormael M, Krajcar M, et al.  Randomized comparison of angioplasty of complex coronary lesions at a single center (the ERBAC study). Circulation. 1997;96:91–98
  20. Mehran R, Mintz GS, Satler LF, et al.  Treatment of in-stent restenosis with excimer laser coronary angioplasty (mechanisms and results compared to PTCA alone). Circulation. 1997;96:2183–2189
  21. Ajani AE, Kim HS, Castagna M, et al.  Clinical utility of the cutting balloon. J Invas Cardiol. 2001;13:554–558
  22. Goldberg S, Savage MP, Fischman DL. Coronary artery stents. Lancet. 1995;345:1523–1524
  23. Serruys PW, van Hout B, Bonnier H, et al.  Randomized comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (BENESTENT II). Lancet. 1998;352:673–681
  24. Savage MP, Fischman DL, Schatz RA, et al.  Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. J Am Coll Cardiol. 1994;24:1207–1212
  25. Fischman DL, Leon MB, Baim DS, et al.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496–501
  26. Serruys PW, De Jaegere P, Kiemeneij F, et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489–495
  27. Versaci F, Gaspardone A, Tomai F, et al.  A comparison of coronary artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med. 1997;336:817–822
  28. Kimura T, Yokoi H, Nakagawa Y, et al.  Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med. 1996;334:561–566
  29. Kimura T, Abe K, Shizuta S, et al.  Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation. 2002;105:2986–2991
  30. Serruys PW, Strauss BH, Beatt K, et al.  Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med. 1991;324:13–17
  31. Gawaz M, Neumann FJ, Ott L, et al.  Platelet activation and coronary stent implantation (effect of antithrombotic therapy). Circulation. 1996;94:279–285
  32. Colombo A, Hall P, Nakamura S, et al.  Intracoronary stenting without anticoagulation accomplished with intravascular guidance. Circulation. 1995;91:1676–1688
  33. Karrillon GJ, Morice MC, Benveiste E, et al.  Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy (30 day clinical outcome of the French Multicenter Registry). Circulation. 1996;94:1519–1527
  34. Schomig A, Neumann FJ, Kastrati A, et al.  A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 1996;334:1084–1089
  35. Leon MB, Baim DS, Popma JJ, et al.  A clinical trial comparing three antithrombotic drug-regimens after coronary-artery stenting. N Engl J Med. 1998;339:1665–1671
  36. Bertrand ME, Rupprecht HJ, Urban P, et al.  the clopidogrel aspirin stent international cooperative study. Circulation. 2000;102:624–629
  37. Cutlip DE, Baim DS, Ho KKL, et al.  Stent thrombosis in the modern era (a pooled analysis of multicenter coronary stent clinical trials). Circulation. 2001;103:1967–1971
  38. Schuhlen H, Kastrati A, Pache J, et al.  Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement (analysis of 5,678 patients with a four-week ticlopidine regimen). J Am Coll Cardiol. 2001;37:2066–2073
  39. Lincoff AM, Califf RM, Topol EJ. Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease. J Am Coll Cardiol. 2000;35:1103–1115
  40. The EPISTENT Investigators . Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with the use of platelet glycoprotein-IIb/IIIa blockade. Lancet. 1998;352:87–92
  41. O'Shea JC, Hafley GE, Greenberg S, et al.  The enhanced suppression of the platelet Ib/IIIa receptor with integrilin therapy. JAMA. 2001;285:2468–2473
  42. Moliterno DJ, Yakubov SJ, Di Battiste PM, et al.  Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization with stent placement. Lancet. 2002;360:355–360
  43. Sigwart U, Urban P, Golf S, et al.  Emergency stenting for acute occlusion after coronary balloon angioplasty. Circulation. 1988;78:1121–1127
  44. Herrmann HC, Buchbinder M, Clemen MW, et al.  Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty. Circulation. 1992;86:812–819
  45. Erbel R, Haude M, Hopp HW, et al.  Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. N Engl J Med. 1998;339:1672–1678
  46. Zalewski A, Goldberg S. PTCA following coronary bypass surgery. Cardiovas Clin. 1998;19:115–127
  47. Foster ED, Fisher LD, Kaiser GC, et al.  Comparison of operative mortality and morbidity for initial and repeat coronary artery bypass grafting (the CASS registry experience). Ann Thorac Surg. 1984;38:563–570
  48. Douglas JS, Gruntzig AR, King SB, et al.  Percutaneous transluminal coronary angioplasty in patients with prior bypass surgery. J Am Coll Cardiol. 1983;2:745–754
  49. Savage MP, Douglas JS, Fischman DL, et al.  Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med. 1997;337:740–747
  50. Baim DS, Wahr D, George B, et al.  Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105:1285–1290
  51. Stone GW, Rogers C, Hermiller J, et al.  Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorta-coronary bypass grafts. Circulation. 2003;108:548–553
  52. Baldus S, Koster R, Elsner M, et al.  Treatment of aortocoronary vein graft lesions with membrane-covered stents (a multicenter surveillance trial). Circulation. 2000;102:2024–2027
  53. Elezi S, Kastrati A, Neumann FJ, et al.  Vessel size and long-term outcome after coronary stent placement. Circulation. 1998;98:1875–1880
  54. Kastrati A, Schuhlen H, Schomig A. Stenting for small coronary vessels (a contestable winner). J Am Coll Cardiol. 2001;38:1604–1607
  55. Regar E, Serruys PW, Bode C, et al.  Sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Circulation. 2002;106:1949–1956
  56. Sirnes PA, Golf S, Myreng Y, et al.  A randomized controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol. 1996;28:1444–1451
  57. Buller CE, Dzavik V, Carere RG. Primary stenting versus balloon angioplasty in occluded coronary arteries. Circulation. 1999;100:236–242
  58. Suero JA, Marso SP, Jones PG, et al.  Procedural outcomes and long-term survival among patients undergoing percutaneous intervention of a chronic total occlusion in native coronary arteries (a 2-year experience). J Am Coll Cardiol. 2001;38:409–414
  59. Grines CL, Browne KF, Marco J, et al.  A comparison of primary angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1993;328:673–679
  60. Al Suwaidi J, Berger PB, Holmes DR. Coronary artery stents. JAMA. 2000;284:1828–1836
  61. Grines CL, Cox DA, Stone GW, et al.  Coronary angioplasty with or without stent implantation in acute myocardial infarction. N Engl J Med. 1999;341:1949–1956
  62. Stone GW, Grines CL, Cox DA, et al.  Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med. 2002;346:957–966
  63. Neumann FJ, Blasini R, Schmitt C, et al.  Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation. 1998;98:2695–2701
  64. Schomig A, Kastrati A, Dirschinger J, et al.  Coronary stenting plus glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 2000;343:385–391
  65. Montalescot G, Barragan P, Wittenberg O, et al.  Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med. 2001;344:1895–1903
  66. Herrmann HC, Moliterno DJ, Ohman EM, et al.  Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction. J Am Coll Cardiol. 2000;36:1489–1496
  67. The BARI Investigators . Seven-year outcome in the BARI trial by treatment and diabetes status. J Am Coll Cardiol. 2000;35:1122–1129
  68. Rodriguez A, Bernardi V, Navia J, et al.  Coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (30-day and one-year follow-up results). J Am Coll Cardiol. 2001;37:51–58
  69. Serruys PW, Unger F, Sousa E, et al.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344:1117–1124
  70. DiMarco J. Results from late-breaking clinical trials sessions at ACC 2001. J Am Coll Cardiol. 2001;38:595–612
  71. Morrison DA, Sethi G, Sacks J, et al.  Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass. J Am Coll Cardiol. 2001;38:143–149
  72. Goldberg S, Savage MP, Fischman DL. The interventional cardiologist and the diabetic patient (have we pushed the envelope too far or not far enough?). Circulation. 1996;94:1804–1806
  73. Van Belle E, Bauters C, Hubert E, et al.  Restenosis rates in diabetic patients (a comparison of coronary stenting and balloon angioplasty in native coronary vessels). Circulation. 1997;96:1454–1460
  74. Abizaid A, Costa MA, Centemero M, et al.  Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients (insights from ARTS trial). Circulation. 2001;104:533–538
  75. Takaro T, Hultgren HN, Lipton MJ. The VA cooperative randomized study of surgery for coronary arterial occlusive disease II (subgroup with significant left main lesions). Circulation. 1976;3:107–117
  76. O'Keefe JH, Hartzler GO, Rutherford BD, et al.  Left main coronary angioplasty (early and late results of 127 acute and elective procedures). Am J Cardiol. 1989;64:144–152
  77. Ellis SG, Tamai H, Nobuyoshi M, et al.  Contemporary percutaneous treatment of unprotected left main coronary stenoses. Circulation. 1997;96:3867–3872
  78. Park SJ, Park SW, Hong MK, et al.  Stenting of unprotected left main coronary artery stenoses (immediate and late outcomes). J Am Coll Cardiol. 1998;31:37–42
  79. Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis (current status and future strategies). J Am Coll Cardiol. 2002;39:183–193
  80. Leon MB, Teirstein PS, Moses JW, et al.  Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med. 2001;344:250–256
  81. Waksman R, Bhargava B, White L, et al.  Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation. 2000;101:1895–1898
  82. Teirstein PS, Moses JW, Leon MB, et al.  Prolonged antiplatelet therapy and reduced stenting eliminates late thrombosis after radiation (the Scripps III trial). J Am Coll Cardiol. 2002;39:65A
  83. Serruys PW, Abizaid A, Foley D, et al.  Sirolimus-eluting stents abolish neointimal hyperplasia in patients with in-stent restenosis (late angiographic and intravascular ultrasound results). J Am Coll Cardiol. 2002;39:37A
  84. Marx SO, Jayaraman T, Go LO, et al.  Rapamycin-KBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res. 1995;76:412–417
  85. Sousa JE, Costa MA, Abizaid A, et al.  Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries. Circulation. 2001;103:192–195
  86. Morice MC, Serruys PW, Sousa JE, et al.  Randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–1780
  87. Park SJ, Shim WH, Ho D. The ASPECT clinical study (12 month clinical follow-up). Circulation. 2002;106:II-394
  88. Silber S, Hauptmann KE, Grube E. A randomized study with the paclitaxel-eluting NIR conformer stent. Circulation. 2002;106:II-394
  89. Gershlick AH, Descheerser I, Chevalier B, et al.  Local drug delivery to inhibit coronary artery restenosis (data from the ELUTES trial). Circulation. 2001;104:II-416
  90. Fajadet J, Perin M, Hayashi EB, et al.  A randomized study with the sirolimus-eluting Bx VELOCITY balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. J Am Coll Cardiol. 2002;39:20A
  91. Sousa JE, Abizaid A, Abizaid A, et al.  Late (two-year) follow-up from the First-In-Man experience after implantation of sirolimus-eluting stents. J Am Coll Cardiol. 2002;39:21A
  92. Moses JW, Leon MB, Popma JJ, et al. A U.S. multicenter, randomized, double-blind study of the SIRolImUS eluting stent in de novo coronary lesion. Presented at: Annual scientific session of transcatheter therapeutic. September 2002; Washington, DC.
  93. Reimers B, Corvaja N, Moshiri S, et al.  Cerebral protection with filter devices during carotid artery stenting. Circulation. 2001;104:12–15
  94. Henry M, Klonaris C, Henry I, et al.  Protected renal stenting with the PercuSurge GuardWire device (a pilot study). J Endovasc Ther. 2001;8:227–237
  95. Berger PB, Steinhubl S. Clinical implications of percutaneous coronary intervention-clopidogrel in unstable angina to prevent recurrent events (PCI-CURE) study (a US perspective). Circulation. 2002;106:2284–2287
  96. Walter DH, Fichtlscherer S, Britten MB, et al.  Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation. J Am Coll Cardiol. 2001;38:2006–2012
  97. Serruys PWJC, de Feyter P, Macaya C, et al.  Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention (a randomized controlled trial). JAMA. 2002;287:3215–3222
  98. Schnyder GS, Roffi M, Flammer Y, et al.  Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med. 2001;345:1593–1600

PII: S0002-8703(03)00153-4

doi: 10.1016/S0002-8703(03)00153-4

American Heart Journal
Volume 146, Issue 5 , Pages 787-796 , November 2003

Article Tools

* Image Usage & Resolution